Please use this identifier to cite or link to this item:
|Title:||Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory||Authors:||Robertson, Mark ;Keighley, C.;Garnham, K.;Harch, S.A.J.;Chaw, K.;Teng, J.C.;Chen, S.C.||Affliation:||Central Coast Local Health District
|Issue Date:||Jun-2021||Source:||15(3):116-126||Journal title:||Current Fungal Infection Reports||Department:||Pathology||Abstract:||PURPOSE OF REVIEW: This review summarises the epidemiology of Candida auris infection and describes contemporary and emerging diagnostic methods for detection and identification of C. auris. RECENT FINDINGS: A fifth C. auris clade has been described. Diagnostic accuracy has improved with development of selective/differential media for C. auris. Advances in spectral databases of matrix-associated laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) systems have reduced misidentification. Direct detection of C. auris in clinical specimens using real time PCR is increasingly used, as is whole genome sequencing (WGS) to track nosocomial spread and to study phylogenetic relationships and drug resistance. SUMMARY: C. auris is an important transmissible, nosocomial pathogen. The microbiological laboratory diagnostic capacity has extended beyond culture-based methods to include PCR and WGS. Microbiological techniques on the horizon include the use of MALDI-TOF MS for early echinocandin antifungal susceptibility testing (AST) and expansion of the versatile and information-rich WGS methods for outbreak investigation.||URI:||https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1983||DOI:||10.1007/s12281-021-00420-y||Pubmed:||https://pubmed.ncbi.nlm.nih.gov/34178208/||ISSN:||1936-3761||Publicaton type:||Journal Article||Keywords:||Infection
|Appears in Collections:||Health Service Research|
Show full item record
checked on Jan 30, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.